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Abstract
Objectives: Low central venous pressure (LCVP)-assisted hepatectomy is associated with decreased
blood loss and lower transfusion rates. Concerns about its impact on renal function have prevented
widespread application. This study was conducted to review the dynamics of renal function after
LCVP-assisted hepatectomy.
Methods: A retrospective analysis of a prospective surgical database was carried out. Estimated
glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease (MDRD)
equation. The RIFLE (risk–injury–failure–loss–end-stage) criteria were used to define postoperative bio-
chemical acute kidney injury (bAKI). Occurrences of clinically relevant AKI (cAKI) were identified in the
study center postoperative database.
Results: During the period 2003–2012, 2116 LCVP-assisted hepatectomies were performed. The
median patient age was 61 years [interquartile range (IQR): 51–70 years] and 51% of patients were
male. The median number of resected segments was two; resections involved from one to four seg-
ments. Median estimated blood loss was 300 ml (IQR: 200–600 ml). Rates of morbidity and 90-day
mortality were 21% and 2%, respectively. Low baseline eGFR (<90 ml/min) was seen in 84% of
patients; 29% of patients had eGFR of <30 ml/min. Postoperative bAKI was seen in 17% (n = 350) of
patients. Biochemical AKI with low eGFR was seen in 336 patients, representing 16% of the whole
cohort; 13% of patients had been at risk, 2% experienced injury and 1% experienced failure. Kidney
function had normalized at discharge in 159 of these patients. Nine patients (<1%) developed
postoperative cAKI.
Conclusions: The majority of patients in the study cohort had low baseline eGFR. Biochemical altera-
tions in eGFR are transient in the vast majority of patients after LCVP-assisted hepatectomy and their
clinical impact is limited. The present data suggest that clinically relevant renal dysfunction is a very
uncommon event in patients undergoing LCVP-assisted liver resection.
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Introduction
Low central venous pressure (LCVP)-assisted liver resection has
been practiced at the Memorial Sloan–Kettering Cancer Center
(MSKCC) for two decades.1,2 This technique, which requires close
collaboration between the surgical and anesthesia teams, has
proven to be safe and reproducible, and to be of value in reducing
the amount of blood loss during hepatic resection. Before routine
application of LCVP, operative haemorrhage during liver resection
commonly led to prohibitively high morbidity and mortality
rates.3–6 In addition to the morbidity and mortality associated with
hypovolaemia and shock, deleterious effects in postoperative mor-
bidity and longterm oncologic outcomes have been shown in
patients receiving blood transfusions after liver resection.7–10
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Although this technique has been shown to be safe and effec-
tive in reducing operative blood loss in several studies evaluating
liver resection and transplantation,11–15 its widespread applica-
tion is still limited. Concerns have been raised about the poten-
tial for morbidity that may derive from the hypoperfusion of
abdominal organs during the LCVP phase of liver resection. Spe-
cifically, the impact that the relative hypotension and potential
hypoperfusion may have on kidney function have been cited
as limiting factors as there is a theoretical risk for
prerenal acute renal failure such as that seen in other types of
operations in which splanchnic and renal circulation may be
compromised.16
The present study was conducted with the aim of evaluating
renal function in a large, recent cohort of patients submitted to
liver resection at a single institution at which the use of
LCVP-assisted liver resection is routine in order to update this
center’s previously published experience.2 This paper reports
postoperative outcomes and evaluates renal function according
to current classification systems based on serum creatinine
and eGFR. Postoperative renal function was evaluated based
on biochemical and clinical criteria and its relationship
with preoperative, operative and postoperative outcomes is
appraised.
Materials and methods
Institutional review board approval was obtained. The study
center’s institutional prospective hepatobiliary database was
queried for patients submitted to liver resection under LCVP.
Demographic, operative and postoperative variables were
extracted. In this center’s database, major liver resection is
defined as resection of three or more segments according to the
Couinaud classification.17 Morbidity was extracted from the
MSKCC Secondary Events Program database. To populate this
database, cases were prospectively reviewed and complications
recorded and graded in severity in a standardized fashion.18 Data
were pooled in a Microsoft Access database. Standard descriptive
statistics were applied. Continuous data are summarized and
reported as the median and interquartile range (IQR) unless
otherwise specified; these variables were compared using t-tests
or the Wilcoxon rank-sum test depending on the distribution.
Categorical data are presented as the total number and percent-
age and compared using the chi-squared or Fisher’s exact test
depending on the number of events. A P-value of <0.05 was con-
sidered to indicate statistical significance. All statistical analyses
were performed using stata Version 12.1 (StataCorp LP, College
Station, TX, USA).
The MSKCC clinical laboratory database was queried to extract
all laboratory results in the present patient population starting
from preoperative baseline until postoperative day (POD) 14 or
discharge, whichever occurred first. Glomerular filtration rate was
estimated (eGFR) using the Modification of Diet in Renal Disease
(MDRD) equation:
eGFR SerumCr age
if patient is black
= × − ∗ − ∗
∗
175 1 154 0 203 1 212
0
. . .
( ) . ( )742 if female 19
Chronic kidney disease (CKD) was evaluated based on the
eGFR and classified according to the National Kidney Found-
ation’s Kidney Disease Outcomes Quality Initiative (KDOQI),
which measures renal function as a measure of eGFR and classifies
it into stages.20 An eGFR of ≥90 ml/min is considered normal.
Subsequent interval reductions are classified as mild dysfunction
(stage 2, eGFR: 60–89 ml/min), moderate dysfunction (stage 3,
eGFR: 30–59 ml/min), severe dysfunction (stage 4, eGFR:
15–29 ml/min) and kidney failure (stage 5, eGFR: <15 ml/min).
The degree of renal dysfunction was evaluated at baseline, at its
lowest level postoperatively, and on POD 14 or at discharge. For
patients who were discharged with an abnormal eGFR, creatinine
levels measured at follow-up were retrieved whenever possible to
evaluate for the resolution of renal dysfunction.
Furthermore, the Acute Dialysis Quality Initiative (ADQI)
guidelines for the definition of acute renal failure in critically ill
patients were used to evaluate the incidence of postoperative bio-
chemical acute kidney injury (AKI) (bAKI) in this population.21
These guidelines were used to develop the RIFLE (risk–injury–
failure–loss–end-stage) classification, which defines AKI based on
the percentage change in eGFR from baseline in response to an
insult and stratifies patients based on the magnitude of this
change. Patients with a decrease of >25% in eGFR are considered
at risk of renal dysfunction; a decrease in eGFR of >50% denotes
kidney injury, and a decrease in eGFR of >75% indicates kidney
failure. Loss of function and end-stage disease represent the com-
plete loss of kidney function for >4 weeks and the presence of
end-stage kidney disease (>3 months), respectively. The incidence
of clinically relevant AKI was estimated from the MSKCC pro-
spective morbidity database and graded in levels of severity. Clini-
cal AKI (cAKI) was defined as oliguria accompanied by elevated
creatinine levels.
This center’s anesthetic approach to LCVP-assisted liver resec-
tion has been previously published.1,2 Intraoperative uid man-
agement is divided into two phases. Prehepatic resection starts at
the induction of anesthesia and ends at the completion of paren-
chymal transection and haemostasis. During this phase, inow
control of the portal vein and hepatic artery is achieved and the
vena cava and hepatic veins are dissected. Hepatic parenchymal
transection is performed, during which intermittent inow
occlusion is applied (Pringle manoeuvre). This phase takes
advantage of uid restriction and the vasodilatory effects of
anesthetic drugs to provide LCVP. Fluid boluses and/or vasoac-
tive drugs are administered at the discretion of the anesthesia
care team to maintain systolic blood pressure (SBP) of
≥90 mmHg and urine output of >25 ml/h while maintaining the
CVP at <5 mmHg. The use of central venous catheters to provide
LCVP-assisted liver resection has been abandoned in this center.
If visual inspection shows the retrohepatic vena cava not to have
collapsed to the surgeon’s satisfaction, sublingual nitroglycerine
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is given to the patient to assist the vasodilation of anesthetic
agents. Maintenance uid is 1 ml/kg/h. The second phase, at
post-hepatic resection, begins once the specimen has been deliv-
ered and haemostasis secured. During this phase, an attempt is
made to return the patient to normovolaemia. Blood loss is
replaced volume-to-volume with albumin or at a ratio of 3 : 1
with crystalloid. Maintenance uids are infused to achieve the
assumed uid requirement 1. After this uid therapy, if SBP is
<90 mmHg or urine output is <25 ml/h, additional uid boluses
either colloid or crystalloid are given. Packed red blood cells are
included in resuscitation if the haemoglobin level is <7 g/dl.
Fresh frozen plasma or platelets may be given at the request of
the surgeon if surgical haemostasis is inadequate, the interna-
tional normalized ratio (INR) is 1.8–2.0, or the platelet count is
<80 000 platelets/μl.
Results
A total of 2116 patients submitted to LCVP-assisted liver resection
between 2003 and 2012 were identified. General demographics are
presented in Table 1. Approximately half (n = 1081, 51%) of the
subjects were male, and the median patient age was 61 years (IQR:
51–70 years). The majority (57%) of patients underwent resection
of colorectal liver metastases, hepatocellular carcinoma (9%) or
cholangiocarcinoma (7%). Most patients had an American
Society of Anesthesiologists (ASA) physical status classification
score of ≤3. Only 16% of patients had a preoperative eGFR of
≥90 ml/min. The majority of the patient population (55%) had
mild dysfunction (eGFR of 60–89 ml/min). None of these patients
were known to have clinically significant renal disease
preoperatively or were on renal replacement therapy.
In this series, most patients underwent segmental resections
(30%), a formal lobectomy (24%), or single- or multiple-wedge
resections (15%) (Table 2). Formal sectoral resections or extended
lobectomies together constituted 23% of all procedures. The
Table 1 Demographic data for 2116 patients submitted to low
central venous pressure-assisted liver resection
Value
Patients, total, n (%) 2116 (100%)
Patients, male, n (%) 1081 (51%)
Age, years, median (IQR) 61 (51–70)
Diagnosis n (%)
Colorectal liver metastases 1204 (57%)
Hepatocellular cancer 198 (9%)
Cholangiocarcinoma 157 (7%)
Gallbladder cancer 111 (5%)
Other metastases 181 (9%)
Benign liver disease 79 (4%)
Other 186 (9%)
ASA class, n (%)
I 18 (<1%)
II 956 (45%)
III 1098 (52%)
IV 43 (2%)
V 1 (<1%)
Preoperative eGFR, n (%)
≥90 ml/min 328 (16%)
60–89 ml/min 1167 (55%)
30–59 ml/min 615 (29%)
15–29 ml/min 4 (<1%)
<15 ml/min (or dialysis) 2 (<1%)
ASA, American Society of Anesthesiologists; eGFR, estimated
glomerular filtration rate; IQR, interquartile range.
Table 2 Operative and postoperative data for 2116 patients submit-
ted to low central venous pressure-assisted liver resection
Value
Procedure, n (%)
Segmental resection 640 (30%)
Lobectomy 503 (24%)
Wedge resection 327 (15%)
Sectorectomy 259 (12%)
Extended lobectomy 230 (11%)
Atypical resection 157 (7%)
Major (≥3 segments) 843 (40%)
Minor (<3 segments) 1273 (60%)
Laparoscopic 100 (5%)
Total segments, n, median (IQR) 2 (1–4)
Pringle time, min, median (IQR) 30 (23–42)
Estimated blood loss, ml, median (IQR) 300 (200–600)
Minor 200 (100–400)
Major 500 (300–800)
Operative time, min, median (IQR) 228 (165–299)
Perioperative transfusion, n (%) 193 (9%)
Overall morbidity, n (%) 448 (21%
Major 217 (10%)
Minor 231 (11%)
90-day mortality, n (%) 36 (2%)
Hospital LOS, days, median (IQR) 7 (6–9)
Renal dysfunction, n (%)
RIFLE 350 (17%)
Risk 29 (14%)
Injury 49 (2%)
Failure 9 (<1%)
Loss/end-stage 0
Clinical grade, n (%) 9 (<1%)
2 8
1 1
IQR, interquartile range; LOS, length of stay.
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median number of segments resected was two (range: one to four)
and 40% of patients underwent a major resection. In two-thirds of
patients (68%), a Pringle manoeuvre was used; the median Pringle
time was 30 min (IQR: 23–42 min). The median estimated blood
loss (EBL) was 300 ml (IQR: 200–600 ml) for the entire popula-
tion and 9% of patients received a perioperative transfusion
(during surgery or in the first 24 h postoperatively). Median blood
loss was higher in major than in minor resections (500 ml versus
200 ml; P < 0.001) and perioperative transfusions were more
common in these patients (13% versus 7%; P < 0.001). Median
operating room time was 228 min (IQR: 165–299 min); the
median time for major resections was 1 h longer than that for
minor resections (263 min versus 200 min; P < 0.001). A total of
5% of patients (n = 100) underwent a laparoscopic resection. Only
8% of these underwent a major resection; in these patients median
EBL was 100 ml (IQR: 50–163 ml) and median operative time was
148 min (IQR: 113–197 min).
The postoperative dynamics of serum creatinine and eGFR
across time are shown in Fig. 1. Mean ± standard deviation (SD)
values for serum creatinine in all patients were 1.0 ± 0.2 at base-
line, 1.1 ± 0.5 at the postoperative peak, and 0.9 ± 0.4 at
discharge. Mean ± SD eGFR values at these time-points were
71.3 ± 22.0 ml/min, 66.7 ± 20.0 ml/min and 87.0 ± 27.0 ml/min,
respectively.
Postoperatively, 21% (n = 448) of patients developed at least
one complication, of which half (n = 231) were major. Mortality at
90 days amounted to 2% (n = 36) and the median length of stay
was 7 days (IQR: 6–9 days) (Table 2). According to the RIFLE
classification, 16% of patients experienced some degree of renal
dysfunction (bAKI). The vast majority of these (83%) fell in the
category of risk, with a reduction in their eGFR of 25–49%.
Kidney injury or failure was seen in 3% of the overall population
(n = 58) (Table 2). Patients who underwent laparoscopic resection
with LCVP (n = 100) had a 26% incidence of bAKI (n = 26); 21 of
these patients were classified as at risk. Fourteen patients had a
persistently low eGFR at discharge. There were no cases of
clinical acute renal failure in patients submitted to laparoscopic
resection.
The distribution of and final outcomes in patients who experi-
enced bAKI are shown in Fig. 2. Patients who maintained an eGFR
of ≥90 ml/min (n = 14) were excluded from this analysis as they
were considered to have normal renal function. Patients classified
as at risk by the ADQI criteria had a higher likelihood of resolving
their renal dysfunction by the time of discharge than those with
injury or failure (50% versus 33%; P < 0.03). Overall, 47% of
patients (n = 159/336) with postoperative bAKI had normal renal
function by the time of discharge. Persistent dysfunction was
present in 8% of the entire cohort (n = 177).
The incidence of cAKI (i.e. oliguria and elevated serum
creatinine) was <1% (n = 9). All of these patients had a baseline
eGFR of <90 ml/min (stage 2, n = 5; stage 3, CKD, n = 4). One
patient who developed multiple organ failure secondary to liver
failure required continuous renal replacement therapy; this patient
died on POD 49 after 17 days of haemodialysis. Discharge eGFR
was persistently low in the remaining eight patients (median:
42 ml/min; IQR: 26–59 ml/min). However, at a median of 2
months of follow-up, eGFR trended to baseline (median: 63 ml/
min; IQR: 53–100 ml/min), and three of the eight patients showed
normal values. All patients returned to their baseline CKD stage
category.
Baseline characteristics and operative and postoperative out-
comes in patients with bAKI (excluding patients categorized as
being at risk) and clinically significant renal dysfunction are pre-
sented in Table 3 and are compared with those in the rest of the
patient population. Postoperative cAKI was more common in
older patients and was associated with larger resections, major
postoperative morbidity and longer length of hospital stay. Opera-
tive blood loss was greater in patients with cAKI, but unlike in
patients with bAKI, this difference did not reach statistical signifi-
cance. Interestingly, patients who ultimately developed bAKI
more commonly had baseline eGFR of ≥90 ml/min (40% versus
16%; P < 0.001).
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Figure 1 Postoperative dynamics of (a) serum creatinine and (b) estimated glomerular filtration rate (eGFR) in 2116 patients undergoing low
central venous pressure-assisted liver resection
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Discussion
Low CVP-assisted liver resection takes advantage of the
anesthetic manipulation of CVP to decrease operative blood loss
during surgery. It has been associated with improved operative
outcomes and is an established technique at certain
institutions.1,2,11–15 Acute kidney injury leading to severe or end-
stage renal dysfunction is a potentially devastating postoperative
complication and is often cited by anesthesiologists to avoid
LCVP-assisted hepatectomy.
AKI: 17%
n = 350
Renal dysfunction: 16%
(n = 336)
Renal dysfunction by eGFR at the time of discharge
eGFR > 90 ml/min
(n = 14)
Failure: < 1%
(n = 9)
Injury: < 2%
(n = 49)
Risk: < 13%
(n = 278)
Resolved
140 (50%)
Resolved
13 (27%)
Resolved
6 (66%)
Persistent
138 (50%)
Persistent
36 (73%)
Persistent
3 (33%)
Figure 2 Classification and outcome of patients experiencing biochemical acute kidney injury (AKI). eGFR: estimated glomerular filtration
rate
Table 3 Characteristics of patients with biochemical and clinical acute kidney injury (AKI)
Biochemical AKI Clinical AKI All patients P-valuea P-valueb
Patients, n 58 9 2116
Males, n (%) 33 (57%) 7 (78%) 1081 (51%) 0.4 0.2
Age, years, median (IQR) 59 (49–68) 72 (66–73) 61 (51–70) 0.3 0.02
Preoperative eGFR, n (%)
≥90 ml/min 23 (40%) 0 328 (16%) <0.001 0.6
60–89 ml/min 20 (34%) 5 (55%) 1167 (55%) 0.002 0.8
<60 ml/min 15 (26%) 4 (44%) 621 (29%) 0.7 0.5
Major resection, n (%) 20 (34%) 6 (67%) 843 (40%) 0.1 0.2
Resected segments, n (range) 2 (1–3) 4 (2–4) 2 (1–4) 1.0 <0.001
Operative time, min, median (IQR) 237 (163–331) 249 (243–310) 228 (165–299) 0.6 0.6
Estimated blood loss, ml, median (IQR) 489 (150–500) 425 (288–525) 300 (200–600) 0.02 0.6
Laparoscopic resection, n (%) 5 (9%) 0 100 (5%) 0.3 –
Perioperative transfusion, n (%) 4 (7%) 2 (22%) 193 (9%) 0.8 0.4
Major morbidity, n (%) 7 (12%) 6 (67%) 217 (10%) 0.8 <0.001
90-day mortality, n (%) 0 1 (1%) 36 (2%) – 0.5
Hospital LOS, days, median (IQR) mean 8 (6–9) 11.5 22 (19–36) 19 7 (6–9) 7.3 0.3 <0.001
aP-values refer to the comparison between all patients and patients with biochemical AKI.
bP-values refer to the comparison between all patients and patients with clinical AKI.
P-values in bold show significance at P < 0.05.
eGFR, estimated glomerular filtration rate; IQR, interquartile range; LOS, length of stay.
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In this study, standard definitions of biochemical renal dysfunc-
tion were applied in a large series of patients submitted to LCVP-
assisted liver resection in the modern era. Findings showed that
although biochemical alterations in renal function are relatively
common, the vast majority of these patients fall into the risk
category and do not develop clinically relevant dysfunction.
Furthermore, alterations in eGFR are transient in nature and in
45% of patients had resolved by the time of discharge. The major-
ity (94%) of patients with persistent biochemical alterations had
mild or moderate renal dysfunction (i.e. eGFR of 30–89 ml/min).
Clinically relevant postoperative AKI was very rare (<1% of the
population), and was also transient and resolved during a short
follow-up period in half of these patients. These results are con-
sistent with previously published national data evaluating postop-
erative morbidity after liver resections22 and other major
surgeries.23
In patients undergoing cardiac and peripheral vascular
operations, which are often accompanied by intraoperative
hypoperfusion, the estimated incidence of postoperative AKI is
8%, a fraction (∼1%) of which results in a requirement for renal
replacement therapy.24,25 In this patient population, age,
increased weight or body mass index, use and duration of car-
diopulmonary bypass, low cardiac ejection fraction and postop-
erative serum creatinine dynamics have been found to be
predictors of the development of acute renal failure.25 The
present investigators did not attempt to generate predictive
models and did not perform any multivariate regression analysis
because the incidence of the outcome of interest was low.
However, postoperative renal dysfunction was more commonly
seen in older patients, which is consistent with the known
decrease in nephron mass that occurs with advanced age.26 Inter-
estingly, the prevalence of preoperative renal dysfunction was
lower in patients who developed bAKI in comparison with the
rest of the population.
The number of segments resected was greater in patients who
developed cAKI. Nevertheless, differences in operative time and
operative EBL did not reach statistical significance. These vari-
ables may be surrogate markers of not only larger resections, but
also of patients with more extensive disease and higher incidences
of intraoperative and postoperative complications, which are
often associated with renal dysfunction.
As might be expected, postoperative renal dysfunction is asso-
ciated with major morbidity and length of hospital stay. In a
Department of Veterans Affairs study, 30-day mortality in patients
who developed postoperative AKI requiring dialysis was 64%,
compared with 4% in patients without AKI.24 The present authors
found a similarly disproportionate mortality rate in patients who
developed bAKI (27%) in comparison with that (2%) in those
who did not. The present study was not designed to evaluate
causality as morbidity and mortality in this patient population are
inuenced by many additional factors.
In addition to technical (operative and anesthetic) factors,
improved perioperative care and the development of specialized
units have led to improved outcomes after liver resection.27 Over
the last few decades, parenchyma-sparing resections have also
improved postoperative morbidity and mortality. In a large series
of patients operated on at the study institution and immediately
predating the present cohort, the number of segments resected
and operative blood loss were the sole factors associated with
perioperative morbidity and mortality.28 Furthermore, in the
current authors’ experience, perioperative complications and use
of blood transfusions are also independent predictors of poor
longterm oncologic outcomes.7–9 Consequently, strategies to
reduce intraoperative blood loss and perioperative transfusions
are of paramount importance in patients undergoing liver resec-
tion. The present group recently completed and published two
clinical trials evaluating acute normovolaemic haemodilution as a
strategy to decrease the use of perioperative blood products and
found this to be a useful tool in selected patients undergoing
major resection.29,30 Trials to evaluate novel perioperative uid
management strategies in patients undergoing hepatobiliary pro-
cedures are ongoing.
The present report is subject to the limitations inherent in
retrospective studies. Furthermore, as the MSKCC was an early
adopter of LCVP-assisted surgery, control data that allow for the
comparison of the outcomes of interest are not available.
However, the current data were collected in a prospective fashion
and were closely monitored by well-established data management
systems at the study institution and are reliable and complete.
Moreover, the present group did not perform a logistic regression
in order to identify factors independently associated with renal
dysfunction. Although this would be useful information, the dis-
tribution of the present data and the very low incidence of the
variables of interest (cAKI and persistent bAKI) would plague
such an analysis with limitations and confounding factors. Thus,
the current data are presented as a descriptive account and in
order to update the group’s experience with LCVP-assisted liver
resection and the incidence of postoperative renal dysfunction.
Conclusions
Although biochemically defined renal dysfunction is a relatively
common event in patients undergoing LCVP-assisted liver resec-
tion, it is a transient phenomenon and its clinical significance is
limited. Clinically relevant renal dysfunction is very uncommon
in this patient population, a finding that is consistent with data in
the published literature regarding other types of major operation.
The oversensitivity of the biochemical classification of renal dys-
function is welcome as it should alert providers to the possibility
of associated adverse outcomes; however, the incidence of bAKI is
not itself an argument against the use of LCVP anesthesia in liver
resections.
Conflicts of interest
None declared.
HPB 263
HPB 2015, 17, 258–264 © 2014 International Hepato-Pancreato-Biliary Association
References
1. Cunningham JD, Fong Y, Shriver C, Melendez J, Marx WL, Blumgart LH.
(1994) One hundred consecutive hepatic resections. Blood loss, transfu-
sion, and operative technique. Arch Surg 129:1050–1056.
2. Melendez J. (1998) Perioperative outcomes of major hepatic resections
under low central venous pressure anaesthesia: blood loss, blood trans-
fusion, and the risk of postoperative renal dysfunction. J Am Coll Surg
187:620–625.
3. Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N et al. (1987)
Hepatic resection for hepatocellular carcinoma. Clinical features and
longterm prognosis. Ann Surg 205:33–40.
4. Nagasue N, Yukaya H, Ogawa Y, Sasaki Y, Chang YC, Niimi K. (1986)
Clinical experience with 118 hepatic resections for hepatocellular carci-
noma. Surgery 99:694–701.
5. Lee CS, Sung JL, Hwang LY, Sheu JC, Chen DS, Lin TY et al. (1986)
Surgical treatment of 109 patients with symptomatic and asymptomatic
hepatocellular carcinoma. Surgery 99:481–490.
6. Foster JH, Berman MM. (1977) Solid liver tumours. Major Probl Clin Surg
22:1–342.
7. Correa-Gallego C, Gonen M, Fischer M, Grant F, Kemeny NE,
Arslan-Carlon V et al. (2013) Perioperative complications influence recur-
rence and survival after resection of hepatic colorectal metastases. Ann
Surg Oncol 20:2477–2484.
8. Ito H, Are C, Gonen M, D'Angelica M, DeMatteo RP, Kemeny NE et al.
(2008) Effect of postoperative morbidity on longterm survival after hepatic
resection for metastatic colorectal cancer. Ann Surg 247:994–1002.
9. Kooby DA, Stockman J, Ben-Porat L, Gonen M, Jarnagin WR, DeMatteo
RP et al. (2003) Influence of transfusions on perioperative and longterm
outcome in patients following hepatic resection for colorectal metasta-
ses. Ann Surg 237:860–869; discussion 869–870.
10. Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR et al. (2009)
Operative blood loss independently predicts recurrence and survival after
resection of hepatocellular carcinoma. Ann Surg 249:617–623.
11. Li Z, Sun YM, Wu FX, Yang LQ, Lu ZJ, Yu WF. (2014) Controlled low
central venous pressure reduces blood loss and transfusion requirements
in hepatectomy. World J Gastroenterol 20:303–309.
12. Wang WD, Liang LJ, Huang XQ, Yin XY. (2006) Low central venous
pressure reduces blood loss in hepatectomy. World J Gastroenterol
12:935–939.
13. Rees M, Plant G, Wells J, Bygrave S. (1996) One hundred and fifty hepatic
resections: evolution of technique towards bloodless surgery. Br J Surg
83:1526–1529.
14. Jones RM, Moulton CE, Hardy KJ. (1998) Central venous pressure and its
effect on blood loss during liver resection. Br J Surg 85:1058–1060.
15. Feng ZY, Xu X, Zhu SM, Bein B, Zheng SS. (2010) Effects of low central
venous pressure during preanhepatic phase on blood loss and liver and
renal function in liver transplantation. World J Surg 34:1864–1873.
16. Sear JW. (2005) Kidney dysfunction in the postoperative period. Br J
Anaesth 95:20–32.
17. Blumgart LH, Hann LE. (2012) Surgical and radiologic anatomy of the
liver, biliary tract, and pancreas. In: Jarnagin WR, Belghiti J, Büchler MW,
Chapman WC, D'Angelica MI, DeMatteo RP, Hann LE, eds. Blumgart's
Surgery of the Liver, Biliary Tract, and Pancreas, 5th edn. Philadelphia,
PA: Saunders, pp. 31–57.
18. Grobmyer SR, Pieracci FM, Allen PJ, Brennan MF, Jaques DP. (2007)
Defining morbidity after pancreaticoduodenectomy: use of a prospective
complication grading system. J Am Coll Surg 204:356–364.
19. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI
et al. (2009) A new equation to estimate glomerular filtration rate. Ann
Intern Med 150:604–612.
20. Stevens PE, Levin A. (2013) Evaluation and management of chronic
kidney disease: synopsis of the kidney disease: improving global out-
comes 2012 clinical practice guideline. Ann Intern Med 158:825–830.
21. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. (2004) Acute
renal failure – definition, outcome measures, animal models, fluid therapy
and information technology needs: the Second International Consensus
Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care
8:R204–R212.
22. Virani S, Michaelson JS, Hutter MM, Lancaster RT, Warshaw AL,
Henderson WG et al. (2007) Morbidity and mortality after liver resection:
results of the patient safety in surgery study. J Am Coll Surg 204:1284–
1292.
23. Bihorac A, Brennan M, Ozrazgat-Baslanti T, Bozorgmehri S, Efron PA,
Moore FA et al. (2013) National surgical quality improvement programme
underestimates the risk associated with mild and moderate postoperative
acute kidney injury. Crit Care Med 41:2570–2583.
24. Chertow GM, Lazarus JM, Christiansen CL, Cook EF, Hammermeister
KE, Grover F et al. (1997) Preoperative renal risk stratification. Circulation
95:878–884.
25. Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP
et al. (1999) Acute renal failure following cardiac surgery. Nephrol Dial
Transplant 14:1158–1162.
26. Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA et al.
(2001) Impaired angiogenesis in the ageing kidney: vascular endothelial
growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis
37:601–611.
27. Dimick JB, Cowan JA Jr, Knol JA, Upchurch GR Jr. (2003) Hepatic
resection in the United States: indications, outcomes, and hospital pro-
cedural volumes from a nationally representative database. Arch Surg
138:185–191.
28. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S et al.
(2002) Improvement in perioperative outcome after hepatic resection:
analysis of 1803 consecutive cases over the past decade. Ann Surg
236:397–406; discussion 406–407.
29. Frankel TL, Fischer M, Grant F, Krone J, D'Angelica MI, DeMatteo RP
et al. (2013) Selecting patients for acute normovolaemic haemodilution
during hepatic resection: a prospective randomized evaluation of
nomogram-based allocation. J Am Coll Surg 217:210–220.
30. Jarnagin WR, Gonen M, Maithel SK, Fong Y, D'Angelica MI, DeMatteo RP
et al. (2008) A prospective randomized trial of acute normovolaemic
haemodilution compared to standard intraoperative management in
patients undergoing major hepatic resection. Ann Surg 248:360–369.
264 HPB
HPB 2015, 17, 258–264 © 2014 International Hepato-Pancreato-Biliary Association
